China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)
16.07
-0.03 (-0.19%)
Nov 6, 2026, 3:00 PM CST
SHA:600062 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, SHA:600062 stock has a consensus rating of "Strong Buy" and an average price target of ¥23.54. The average 1-year stock price forecast is 46.48% higher than the current stock price, while the lowest is ¥22.50 (+40.01%) and the highest is ¥24.57 (+52.89%).
Price Target: ¥23.54 (+46.48%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for SHA:600062 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
10.87B
from 11.00B
Decreased by -1.22%
Revenue Next Year
11.45B
from 10.87B
Increased by 5.32%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is CNY.